Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

TG Therapeutics, Inc. TGTX

Full chart Compare
Set alert

Price alert · TGTX

All alert types
59.83 USD +1.85 (+3.18%)

At closeNov 6, 2026, 7:45 PM EST

59.75 -0.08 -0.13%

After hours · Nov 6, 7:45 PM ET

57.59 Day range 60.82
26.94 52-week range 61.63
YTD
+100.69%
1 year
+79.87%

Financial health

Altman Z-Score

5.81 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B3 / 5 overall

  • DCF 2
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 1
  • P/E 3
  • P/B 1

Valuation

P/E 9.6×
FY 2016: -2.9×FY 2017: -4.3×FY 2018: -1.8×FY 2019: -5.7×FY 2020: -21.5×FY 2021: -7.2×FY 2022: -8.1×FY 2023: 191×FY 2024: 188×FY 2025: 9.6×
FY 2016 5y median 9.6× FY 2025
P/S 7.0×
FY 2016: 1497×FY 2017: 3340×FY 2018: 2036×FY 2019: 6453×FY 2020: 39471×FY 2021: 376×FY 2022: 575×FY 2023: 10.4×FY 2024: 13.3×FY 2025: 7.0×
FY 2016 5y median 13.3× FY 2025
P/B 6.6×
FY 2016: 6.4×FY 2017: 7.6×FY 2018: 12.9×FY 2019: 25.4×FY 2020: 11.6×FY 2021: 10.6×FY 2022: 27.3×FY 2023: 15.1×FY 2024: 19.7×FY 2025: 6.6×
FY 2016 5y median 15.1× FY 2025
P/FCF -172×
FY 2016: -3.7×FY 2017: -5.4×FY 2018: -2.4×FY 2019: -7.4×FY 2020: -27.9×FY 2021: -8.5×FY 2022: -9.1×FY 2023: -77.2×FY 2024: -108×FY 2025: -172×
FY 2016 5y median -77.2× FY 2025
EV/EBITDA 33.4×
FY 2016: -2.6×FY 2017: -3.8×FY 2018: -1.5×FY 2019: -5.4×FY 2020: -20.1×FY 2021: -6.7×FY 2022: -7.4×FY 2023: 93.6×FY 2024: 89.1×FY 2025: 33.4×
FY 2016 5y median 33.4× FY 2025
EV/Sales 7.3×
FY 2016: 1333×FY 2017: 2969×FY 2018: 1760×FY 2019: 5981×FY 2020: 36107×FY 2021: 343×FY 2022: 568×FY 2023: 10.5×FY 2024: 13.5×FY 2025: 7.3×
FY 2016 5y median 13.5× FY 2025
FCF Yield -0.6%
FY 2016: -27.2%FY 2017: -18.4%FY 2018: -41.7%FY 2019: -13.6%FY 2020: -3.6%FY 2021: -11.8%FY 2022: -11.0%FY 2023: -1.3%FY 2024: -0.9%FY 2025: -0.6%
FY 2016 5y median -1.3% FY 2025

Profitability

Gross Margin 83.7%
FY 2016: 58.7%FY 2017: 46.0%FY 2018: 42.1%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 88.2%FY 2022: 90.5%FY 2023: 94.0%FY 2024: 88.3%FY 2025: 83.7%
FY 2016 5y median 88.3% FY 2025
Operating Margin 20.0%
FY 2016: -51823.5%FY 2017: -77904.6%FY 2018: -114736.8%FY 2019: -111220.4%FY 2020: -179996.1%FY 2021: -5154.3%FY 2022: -7839.0%FY 2023: 8.8%FY 2024: 12.7%FY 2025: 20.0%
FY 2016 5y median 8.8% FY 2025
Net Margin 72.6%
FY 2016: -51353.4%FY 2017: -77749.9%FY 2018: -114132.9%FY 2019: -113730.9%FY 2020: -183803.3%FY 2021: -5204.1%FY 2022: -8036.3%FY 2023: 5.4%FY 2024: 7.1%FY 2025: 72.6%
FY 2016 5y median 5.4% FY 2025
ROE 69.0%
FY 2016: -218.2%FY 2017: -176.8%FY 2018: -721.8%FY 2019: -447.7%FY 2020: -53.8%FY 2021: -146.8%FY 2022: -382.0%FY 2023: 7.9%FY 2024: 10.5%FY 2025: 69.0%
FY 2016 5y median 7.9% FY 2025
ROIC 13.5%
FY 2016: -206.1%FY 2017: -170.3%FY 2018: -387.0%FY 2019: -210.8%FY 2020: -48.7%FY 2021: -108.9%FY 2022: -153.8%FY 2023: 7.2%FY 2024: 7.8%FY 2025: 13.5%
FY 2016 5y median 7.2% FY 2025
ROA 42.1%
FY 2016: -142.8%FY 2017: -121.7%FY 2018: -207.5%FY 2019: -106.0%FY 2020: -44.7%FY 2021: -91.7%FY 2022: -115.6%FY 2023: 3.8%FY 2024: 4.0%FY 2025: 42.1%
FY 2016 5y median 3.8% FY 2025

Growth (YoY)

Revenue 87.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -0.3%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 4300.7%FY 2022: -58.4%FY 2023: 8290.0%FY 2024: 40.8%FY 2025: 87.3%
FY 2016 FY 2025
Operating Income 194.1%
FY 2016: -25.0%FY 2017: -50.3%FY 2018: -46.9%FY 2019: 3.1%FY 2020: -61.8%FY 2021: -26.0%FY 2022: 36.7%FY 2023: 109.5%FY 2024: 103.2%FY 2025: 194.1%
FY 2016 FY 2025
EPS (diluted) 1746.7%
FY 2016: -15.9%FY 2017: -19.4%FY 2018: -20.4%FY 2019: 14.8%FY 2020: -23.5%FY 2021: -8.7%FY 2022: 44.5%FY 2023: 105.8%FY 2024: 75.8%FY 2025: 1746.7%
FY 2016 FY 2025
Free Cash Flow 38.4%
FY 2016: -38.5%FY 2017: -51.4%FY 2018: -37.6%FY 2019: -3.0%FY 2020: -61.6%FY 2021: -37.8%FY 2022: 40.5%FY 2023: 82.2%FY 2024: -29.1%FY 2025: 38.4%
FY 2016 FY 2025

Financial Health

Current Ratio 4.1×
FY 2016: 3.0×FY 2017: 3.3×FY 2018: 2.0×FY 2019: 1.8×FY 2020: 7.0×FY 2021: 5.1×FY 2022: 3.2×FY 2023: 5.9×FY 2024: 6.2×FY 2025: 4.1×
FY 2016 5y median 5.1× FY 2025
Quick Ratio 3.3×
FY 2016: 2.7×FY 2017: 3.1×FY 2018: 1.8×FY 2019: 1.8×FY 2020: 7.0×FY 2021: 5.1×FY 2022: 3.2×FY 2023: 5.2×FY 2024: 5.0×FY 2025: 3.3×
FY 2016 5y median 5.0× FY 2025
Debt / Equity 0.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 1.1×FY 2020: 0.1×FY 2021: 0.3×FY 2022: 1.4×FY 2023: 0.7×FY 2024: 1.1×FY 2025: 0.4×
FY 2016 5y median 0.7× FY 2025
Net Debt / EBITDA 1.4×
FY 2016: 0.3×FY 2017: 0.5×FY 2018: 0.2×FY 2019: 0.4×FY 2020: 1.9×FY 2021: 0.6×FY 2022: 0.1×FY 2023: 0.7×FY 2024: 1.5×FY 2025: 1.4×
FY 2016 5y median 0.7× FY 2025
Interest Coverage 4.6×
FY 2016: 0.0×FY 2017: -104×FY 2018: -101×FY 2019: -32.0×FY 2020: -43.2×FY 2021: -61.2×FY 2022: -21.4×FY 2023: 1.6×FY 2024: 1.7×FY 2025: 4.6×
FY 2016 5y median 1.6× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31